SCWorx (WORX) Research & Development (2019)

SCWorx (WORX) posted Research & Development of $198450.0 for Q3 2019, down 58.48% sequentially from $477950.0 in Q2 2019.

SCWorx (WORX) Research & Development (2019) Analysis & Trends

SCWorx has reported Research & Development for 1 years, with the latest figure at $198450.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 208.32 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 26.83 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 56.79 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 81.41 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 99.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 50.38 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 45.05 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 30.58 Mn
10 SCWorx 5.87 Mn 4.53 Mn 330,423.00 -

Historic Data

Download Data
DateValue
Sep 30, 2019 198,450.00
Jun 30, 2019 477,950.00
Mar 31, 2019 182,339.00